Concepedia

A randomised open-label study of tiagabine given two or three times daily in refractory epilepsy

Santiago Arroyo, Bernard Boothman, Martin J. Brodie, John S. Duncan, Roderick Duncan, M Nieto, Elena P. Calandre, I Forcadas, Pamela Crawford

Seizure · 2005 · 14 citations · 2 references

Concepts

MedicinePharmacologyPharmacotherapyClinical PharmacologyEpilepsyNeuropharmacologyAntiepileptic PharmacologyAntiepileptic PharmacotherapyDrug-resistant EpilepsySeizure ManagementOpen-label TrialsRefractory Epilepsy CareRefractory Epilepsy TreatmentTreatment-resistant EpilepsyTreatment-resistant Seizures

References

2

Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme-inducing antiepilepsy drugs

Elson L. So, Denise L Wolff, Nina M. Graves et al. · Epilepsy Research · 1995 · 61 citations

Medicine, Pharmacokinetics, Pharmacology +9

Comparison of twice‐ and three times daily tiagabine for the adjunctive treatment of partial seizures in refractory patients with epilepsy: an open label, randomised, parallel‐group study

Arnaud Biraben, M Beaussart, Étienne Josien et al. · Epileptic Disorders · 2001 · 16 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15